enGene Therapeutics (ENGN) Net Equity Issued and Repurchased (2023 - 2026)
enGene Therapeutics (ENGN) recorded Net Equity Issued and Repurchased of -$103 million in fiscal Q2 2026 (quarter ended Apr 30, 2026), compared with $199,000 a year earlier.
Powered by 
Analysis
enGene Therapeutics (ENGN) Net Equity Issued and Repurchased (2023 - 2026) Analysis & Trends
For FY2025 (ended Oct 31, 2025), enGene Therapeutics reported Net Equity Issued and Repurchased of $2.22 million, down 99.1% from FY2024.
- Annual Net Equity Issued and Repurchased has a three-year compound annual growth rate of 470.1% (FY2022 to FY2025).
- Across earlier fiscal years, Net Equity Issued and Repurchased came in at $260.15 million in FY2024 (+357.3%), $56.89 million in FY2023 and $12,000 in FY2022.
- The fiscal Q2 2026 figure is the lowest quarterly Net Equity Issued and Repurchased in data going back to fiscal Q4 2023.
- Per Business Quant, the preceding three fiscal quarters came in at $126.25 million (Q1 2026), $1.99 million (Q4 2025) and $32,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | -377.00 Mn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | -966.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | -5.00 Mn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | -406.00 Mn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | -283.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | - |
| 10 | enGene Therapeutics | 161.50 Mn | -832.97 Mn | - | 23,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 23,000.00 |
| Apr 30, 2026 | 4,000.00 |
| Jan 31, 2026 | 149.78 Mn |
| Oct 31, 2025 | 1.99 Mn |
| Jul 31, 2025 | 32,000.00 |
| Apr 30, 2025 | 199,000.00 |
| Jan 31, 2025 | 1,000.00 |
| Oct 31, 2024 | 60.16 Mn |
| Jul 31, 2024 | 51,000.00 |
| Oct 31, 2023 | 56.92 Mn |
API Access
enGene Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ENGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();